Conservative surgical treatment of post-partum hemorrhage: Should we reconsider compression penetrating sutures?


Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 11 04 2022
revised: 19 10 2022
accepted: 23 10 2022
pubmed: 29 10 2022
medline: 2 12 2022
entrez: 28 10 2022
Statut: ppublish

Résumé

Evaluate the prevalence of uterine synechia after total uterine ligation (TUL) in comparison to TUL associated with compression-penetrating-sutures (CPS) in the conservative surgical management of severe postpartum hemorrhage (PPH). Prospective observational study of pregnant women that underwent conservative surgical management for PPH in a single French tertiary referral center. We compared the risk of uterine synechia with TUL, in comparison to performing TUL in addition to CPS. The synechia rate was calculated after uterine cavity assessment by 3D hysterosonography. Hysterectomies, women with placenta accreta spectrum and patients that received additional embolization treatment were excluded. Over 6 years, 36 pregnant women underwent surgical treatment for PPH in 21,944 deliveries (1.64 per 1000). The median blood loss was 2700 [1570-3000] milliliters. Twenty-eight (77.7%) women underwent TUL, 8/36 (22.2%) underwent TUL in addition to CPS. Thirty-four (94,4%) cavity assessments were performed 2-to-6 months after delivery, since one woman of each group was lost to follow-up. When TUL was performed in addition to CPS, the prevalence of synechia was 42.9% (n = 3/7), versus 3.7% (n = 1/27) in TUL (p = 0.021; RR = 16.88, 95%CI [1.1-1051]). Synechia was absent in 30/34 (88.2%) women. The prevalence of synechia was very low after TUL unlike CPS. Further studies should evaluate TUL in the conservative surgical management of PPH, to confirm the lower prevalence of synechiae in TUL and evaluate its impact on fertility.

Identifiants

pubmed: 36307022
pii: S2468-7847(22)00178-7
doi: 10.1016/j.jogoh.2022.102495
pii:
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102495

Informations de copyright

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors declare that they have no conflict of interest.

Auteurs

Anthony Atallah (A)

Hospices Civils de Lyon, Hôpital Femme Mère Enfant, Maternal-Fetal Medicine and Obstetric Emergency Department, Groupement Hospitalier Est, 59 Boulevard Pinel 69500 Bron, France; Claude Bernard University Lyon 1, 8 avenue Rockefeller 69008 Lyon, France; University Hospital Centre Sainte Justine, Department of Maternal Fetal Medicine, University of Montreal, 3175 Chemin de la Côte-Sainte-Catherine H3T 1C5 Montréal, Québec Canada. Electronic address: anthony.atallah@chu-lyon.fr.

Chloé Trably (C)

Hospices Civils de Lyon, Croix Rousse University Hospital, Department of Obstetrics and Gynecology, 93 Grande rue de la Croix- Rousse, 69004 Lyon, France.

Gil Dubernard (G)

Claude Bernard University Lyon 1, 8 avenue Rockefeller 69008 Lyon, France; Hospices Civils de Lyon, Croix Rousse University Hospital, Department of Obstetrics and Gynecology, 93 Grande rue de la Croix- Rousse, 69004 Lyon, France.

R-C Rudigoz (RC)

Claude Bernard University Lyon 1, 8 avenue Rockefeller 69008 Lyon, France; Hospices Civils de Lyon, Croix Rousse University Hospital, Department of Obstetrics and Gynecology, 93 Grande rue de la Croix- Rousse, 69004 Lyon, France.

Marion Cortet (M)

Claude Bernard University Lyon 1, 8 avenue Rockefeller 69008 Lyon, France; Hospices Civils de Lyon, Croix Rousse University Hospital, Department of Obstetrics and Gynecology, 93 Grande rue de la Croix- Rousse, 69004 Lyon, France.

C Huissoud (C)

Hospices Civils de Lyon, Hôpital Femme Mère Enfant, Maternal-Fetal Medicine and Obstetric Emergency Department, Groupement Hospitalier Est, 59 Boulevard Pinel 69500 Bron, France; Claude Bernard University Lyon 1, 8 avenue Rockefeller 69008 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH